KEC International Ltd secured new orders worth 1,445 crore for T&D projects, including ±800 kV HVDC and 400 kV transmission ...

The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.

Read here for an analysis on Humacyte (HUMA) stock post-Symvess approval, potential upside in revenue generation, and ...

Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a market capitalization of $228 million, is a clinical-stage biopharmaceutical ...

Phillip A. Sharp (OTC:SHCAY), a director at Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), executed a significant stock ...

J&J JNJ announced fourth-quarter and full-year 2024 results, starting the earnings season for the drug and biotech sector.

Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 ...

Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the ...

H.C. Wainwright's valuation of Microbot Medical (NASDAQ:MBOT) stands at an estimated market value of $255 million, or $9 per share, which underpins the revised price target. The current market ...

The firm's positive outlook is also based on Eton's consistent year-over-year revenue growth, with current revenues at $34.68 million and an impressive gross margin of 59.3%. H.C. Wainwright forecasts ...